Prostate Cancer in African American Men: High Mutation Frequency in Key Cancer Drivers

Because most prostate cancer clinical studies have been performed in patients of European ancestry, the prevalence of actionable mutations in prostate cancer among minority patients (African Americans and others) and their responsiveness to targeted therapies remain poorly defined.

Read the full article here

Related Articles